Skip to main content
SpringerLink
Log in

Anal Cancer

  • Chapter
  • First Online:
Gastrointestinal Oncology

  • 1664 Accesses

Abstract

Squamous cell cancer (SCC) of the anus is rare and accounts for only 2–4% of all lower alimentary tract malignancies. A multidisciplinary approach is essential with close co-operation and communication required between radiologist, surgeon, medical oncologist, radiation oncologist, pathologist and nursing specialists. An indolent natural history and a low rate of distant metastases means anal cancer is usually amenable to loco-regional treatment. Randomized controlled studies in Europe and the United States have confirmed that synchronous chemoradiation (SCRT), using mitomycin and 5-fluorouracil as the primary modality, is superior to radiotherapy alone in the treatment of anal cancer. Local control has improved but the relative 5-year survival rate has changed little for patients treated in the last two decades. The aim of this chapter is to summarize the available evidence and to define the role of imaging, chemoradiation-based, chemotherapy and surgical treatment options. We hope this chapter provides a useful and practical update.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

14.37 Guidelines

  • •Engstrom PF, Amoletti JP, Benson AB, et al., NCCN Practice Guidelines: Anal Cancer Version 2. 2009 (08/19/09). Available at www.nccn.org/professionals/physician (last accessed September 27 2009)

  • •Guidelines for the management of Colorectal cancer issued by the Association of Coloproctology of Great Britain and Ireland; 3rd Edition 2007.

    Google Scholar 

  • •Fleshner PR, Chalasani S, Chang GJ et al., Practice parameters for anal squamous neoplasms. Dis Colon Rectum 2008;51:2–9.

    Article  PubMed  Google Scholar 

  • •Glynne-Jones R, Northover J, Oliveira J. ESMO Guidelines Working Group. Anal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2009; 20(4):57–60.

    Article  PubMed  Google Scholar 

14.38 Reviews

  • Poggi MM, Suh WW, Saltz L et al (2007) ACR Appropriateness Criteria on treatment of anal cancer. J Am Coll Radiol 4:448–456

    Article  PubMed  Google Scholar 

  • Uronis HE, Bendell JC (2007) Anal cancer: an overview. The Oncologist 12(5):524–534

    Article  PubMed  Google Scholar 

  • Das P, Crane C, Ajani J (2007) Current treatment of localized anal carcinoma. Curr Opin Oncol 19:396–400

    Article  CAS  PubMed  Google Scholar 

  • Fleshner PR, Chalasani S, Chang GJ et al (2008) Practice parameters for anal squamous neoplasms. Dis Colon Rectum 51:2–9

    Article  PubMed  Google Scholar 

  • Czito BG, Willett CG (2009) Current management of anal canal cancer. Curr Oncol Rep 11(3):186–192

    Article  CAS  PubMed  Google Scholar 

  • Buchs NC, Allal AS, Morel P, Gervaz P (2009) Prevention, chemoradiation and surgery for anal cancer. Expert Rev Anticancer Ther 9(4):483–489

    Article  PubMed  Google Scholar 

  • Eng C, Pathak P (2008) Treatment options in metatstatic squamous cell carcinoma of the anal canal. Curr treat Options Oncol 9 (4–6):400–407

    Article  PubMed  Google Scholar 

References

  • Frisch M, Melbye M, Moller H (1993) Trends in incidence of anal cancer in Denmark. BMJ 306:419–422

    Article  CAS  PubMed  Google Scholar 

  • Johnson LG, Madeleine MM, Newcomer LM et al (2004) Anal cancer incidence and survival: the surveillance, epidemiology and end results experience, 1973–2000. Cancer 101:281–288

    Article  PubMed  Google Scholar 

  • Bilimoria KY, Bentrem DJ, Rock CE et al (2009) Outcomes and prognostic factors for squamous-cell carcinoma of the anal canal: analysis of patients from the National Cancer Data Base. Dis Colon Rectum 52(4):624–631

    PubMed  Google Scholar 

  • Jemal A, Siegel R, Ward E et al (2008) Cancer statistics. CA. Cancer J Clin 58:71–96

    Article  Google Scholar 

  • Boman BM, Moertel CG, O’Connell MJ, Scott M, Weiland LH, Beart RW, Gunderson LL, Spencer RJ (1984) Carcinoma of the anal canal. A clinical and pathologic study of 188 cases. Cancer 54:114–125

    Article  CAS  PubMed  Google Scholar 

  • UKCCCR Anal Cancer Working Party (1996) Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil and Mitomycin C. Lancet 348:1049–1054

    Article  Google Scholar 

  • Miller BA, Ries LAG, Hankey BF et al (1992) SEER cancer statistics review 1973–1989. NIH pub No 94-2789. National Cancer Institute, Bethesda

    Google Scholar 

  • Williams GR, Lu QL, Love SB et al (1996) Properties of HPV-positive and HPV-negative anal carcinomas. J Pathol 180(4):378–382

    Article  CAS  PubMed  Google Scholar 

  • Frisch M, Glimelius B, Van Den Brule AJ et al (1997) Sexually transmitted infection as a cause of anal cancer. N Engl J Med 337(19):1350–1358

    Article  CAS  PubMed  Google Scholar 

  • Crook T, Wrede D, Tody J et al (1991) Status of c-myc, p53 and retinoblastoma genes in human papillomavirus positive and negative squamous cell carcinomas of the anus. Oncogene 6(7):1251–1257

    CAS  PubMed  Google Scholar 

  • Bosch FX, Manos MM, Munoz N et al (1995) Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 87(11):796–802

    Article  CAS  PubMed  Google Scholar 

  • Frisch M, Fender C, Vandenbruller AJC et al (1999a) Varieties of squamous cell carcinoma of the anal canal and peri-anal skin and their relation to human papilloma viruses. Cancer Res 59:753–757

    CAS  PubMed  Google Scholar 

  • Licitra L, Perrone F, Bossi P et al (2006) High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol 24:5630–5636

    Article  CAS  PubMed  Google Scholar 

  • Penn I (1986) Cancers of the anogenital region in renal transplant recipients: analysis of 65 cases. Cancer 58:611–616

    Article  CAS  PubMed  Google Scholar 

  • Daling JR, Weiss NS, Klopfenstein LL et al (1982) Correlates of homosexual behaviour and the incidence of anal cancer. JAMA 247:1988–1990

    Article  CAS  PubMed  Google Scholar 

  • Daling JR, Weiss NS, Hislop TJ et al (1987) Sexual practices, sexually transmitted diseases and the incidence of anal cancer. N Eng J Med 317:973–978

    Article  CAS  Google Scholar 

  • Melbye M, Cote TR, Kessler L et al (1994) High incidence of anal cancer among AIDS patients. The AIDS/Cancer Working Group. Lancet 343:636–639

    Article  CAS  PubMed  Google Scholar 

  • Holly EA, Whittemore AS, Aston DA et al (1989) Anal cancer incidence: genital warts, anal fissure or fistula, hemorrhoids, and smoking. J Natl Cancer Inst 81:1726–1731

    Article  CAS  PubMed  Google Scholar 

  • Daling JR, Sherman KJ, Hislop TG et al (1992) Cigarette smoking and the risk of anogenital cancer. Am J Epidemiol 135:180–189

    CAS  PubMed  Google Scholar 

  • Tseng HF, Morgenstern H, Mack TM, Peters RK (2003) Risk factors for anal cancer: results of a population-based case-control study. Cancer Causes Control 14:837–846

    Article  PubMed  Google Scholar 

  • Frisch M, Glimelius B, Wohlfahrt J et al (1999b) Tobacco smoking as a risk factor in anal carcinoma: an antiestrogenic mechanism? J Natl Cancer Inst 91:708–715

    Article  CAS  PubMed  Google Scholar 

  • Frisch M, Olsen JH, Bautz A et al (1994) Benign anal lesions and the risk of anal cancer. N Engl J Med 331:300–302

    Article  CAS  PubMed  Google Scholar 

  • Frisch M, Johansen C (2000) Anal carcinoma in inflammatory bowel disease. Br J Cancer 83:89–90

    Article  CAS  PubMed  Google Scholar 

  • Daling JR, Madeleine MM, Johnson LG et al (2004) Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 101(2):270–280

    Article  PubMed  Google Scholar 

  • Schofield JH, Castle MT, Watson NFS (2005) Malignant transformation of high-grade anal intra-epithelial neoplasia. Br J Surg 92:1133–1136

    Article  Google Scholar 

  • Lacey HB, Wilson GE, Tilston P et al (1999) Anal squamous intraepithelial lesions in HIV-positive and HIV – negative homosexual and bisexual men. Sex Transm Infect 75:172–177

    Article  CAS  PubMed  Google Scholar 

  • Zbar AP, Fenger C, Efron J et al (2002) The pathology and molecular biology of anal intraepithelial neoplasia: comparisons with cervical and vulvar intraepithelial neoplasia. Int J Colorectal Dis 17:203–215

    Article  CAS  PubMed  Google Scholar 

  • Abbasakoor F, Boulos PB (2005) Anal intraepithelial neoplasia. Br J Surg 92:277–290

    Article  CAS  PubMed  Google Scholar 

  • Shepherd NA, Scoffield JH, Love SB et al (1990) Prognostic factors in anal squamous carcinoma: a multi variant analysis of clinical, pathological and flow cytometric perimeters in 235 cases. Histopathology 16:545–555

    Article  CAS  PubMed  Google Scholar 

  • Wendell-Smith CP (2000) Anorectal nomenclature. Fundamental terminology. Dis Colon Rectum 43:1349–1358

    Article  CAS  PubMed  Google Scholar 

  • Hill JH, Meadows H, Haboubi N et al (2003) Pathological staging of epidermoid anal cancer for the new era. Colorect Dis 5(3):206–213

    Article  CAS  Google Scholar 

  • Wade DS, Herrera L, Castillo NB et al (1986) Metastases to the lymph nodes in epidermoid carcinoma of the anal canal studied by a clearing technique. Cancer 57:400–406

    Article  Google Scholar 

  • Beahrs OH, Wilson SM (1976) Carcinoma of the anus. Ann Surg 184:422–428

    Article  CAS  PubMed  Google Scholar 

  • Stearns MW, Urmacher C, Sternberg SS (1980) Cancer of the anal canal. Curr Probl Cancer 4:1–44

    Article  PubMed  Google Scholar 

  • Greene FL, Page DL, Fleming ID et al (eds) (2002) AJCC Staging Manual, 6th edn. Springer, New York, pp 125–130

    Google Scholar 

  • Greenall MJ, Quan SH, Urmacher C, DeCosse JJ (1985) Treatment of epidermoid carcinoma of the anal canal. Surg Gynecol Obstet 161(6):509–517

    CAS  PubMed  Google Scholar 

  • Sato H, Koh PK, Bartolo DC (2005) Management of anal canal cancer. Dis Colon Rectum 48(6):1301–1315

    Article  PubMed  Google Scholar 

  • Touboul E, Schlienger M, Buffat L, Lefkopoulos D, Pene F, Parc R et al (1994) Epidermoid carcinoma of the anal canal. Results of curative-intent radiation therapy in a series of 270 patients. Cancer 73:1569–1579

    Article  CAS  PubMed  Google Scholar 

  • Pyper PC, Parks TG (1985) The results of surgery for epidermoid carcinoma of the anus. Br J Surg 72(9):712–714

    Article  CAS  PubMed  Google Scholar 

  • Clark J, Petrelli N, Herrera L, Mittelman A (1986) Epidermoid carcinoma of the anal canal. Cancer 57(2):400–406

    Article  CAS  PubMed  Google Scholar 

  • Roach SC, Hulse PA, Moulding FJ et al (2005) Magnetic resonance imaging of anal cancer. Clin Radiol 60(10):1111–1119

    Article  CAS  PubMed  Google Scholar 

  • Salerno G, Daniels IR, Brown G (2006) Magnetic resonance imaging of the low rectum: defining the radiological anatomy. Colorectal Dis 8(suppl 3):10–13

    Article  PubMed  Google Scholar 

  • Koh DM, Dzik Jurasz A, O’Neill B et al (2008) Pelvic phased array MR imaging of anal carcinoma before and after chemoradiation. Br J Radiol 81:91–98

    Article  CAS  PubMed  Google Scholar 

  • Magdeburg B, Fried M, Meyenberger C (1999) Endoscopic ultrasonography in the diagnosis, staging, and follow-up of anal carcinomas. Endoscopy 31(5):359–364

    Article  CAS  PubMed  Google Scholar 

  • Giovannini M, Bardou VJ, Barclay R et al (2001) Anal carcinoma: prognostic value of endorectal ultrasound (ERUS). Results of a prospective multicenter study. Endoscopy 33:231–236

    Article  CAS  PubMed  Google Scholar 

  • Berton F, Gola G, Wilson SR (2008) Perspective on the role of transrectal and transvaginal sonography of tumors of the rectum and anal canal. AJR Am J Roentgenol 190(6):1495–1504, Review

    Article  PubMed  Google Scholar 

  • Otto SD, Lee L, Buhr HJ et al (2009) Staging anal cancer: prospective comparison of transanal endoscopic ultrasound and magnetic resonance imaging. J Gastrointest Surg 13(7):1292–1298

    Article  CAS  PubMed  Google Scholar 

  • Kuehn PG, Eisenberg H, Reed JF (1968) Epidermoid carcinoma of the perianal skin and anal canal. Cancer 22(5):932–938

    Article  CAS  PubMed  Google Scholar 

  • Trautmann TG, Zuger JH (2005) Positron emission tography for pre-treatment staging and postreatment evaluation in cancer of the anal canal. Mol Imaging Biol 7:309–313

    Article  PubMed  Google Scholar 

  • Cotter SE, Grigsby PW, Siegel BA et al (2006) FDG-PET/CT in the evaluation of anal carcinoma. Int J Radiat Oncol Biol Phys 65:720–725

    PubMed  Google Scholar 

  • Engstrom PF, Amoletti JP, Benson AB et al www.nccn.org/professionals/physicianls/PDF/anal.pdf. Accessed 13 March 2008

  • Koh DM, Brown G, Temple L et al (2004) Rectal cancer: mesorectal lymph nodes at MR imaging with USPIO versus histopathologic findings – initial observations. Radiology 231:91–99

    Article  PubMed  Google Scholar 

  • Mai SK, Welzel G, Haegele V, Wenz F (2007) The influence of smoking and other risk factors on the outcome after chemoradiotherapy for anal cancer. Radat Oncol 2:30

    Article  Google Scholar 

  • Gerard JP, Ayzac L, Hun D et al (1998) Treatment of anal canal carcinoma with high dose radiation therapy and concomitant fluorouracil-cisplatinum: long term results in 95 patients. Radiother Oncol 46:249–256

    Article  CAS  PubMed  Google Scholar 

  • Doci R, Zucali R, La Monica G, Meroni E, Kenda R, Eboli M, Lozza L (1996) Primary chemoradiation therapy with fluorouracil and cisplatin for cancer of the anus: results in 35 consecutive patients. J Clin Oncol 14:3121–3125

    CAS  PubMed  Google Scholar 

  • Bartelink H, Roelofsen F, Eschwege F, Rougier P, Bosset JF, Gonzalez DG et al (1997) Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 15:2040–2049

    CAS  PubMed  Google Scholar 

  • Flam M, John M, Pajak TF, Petrelli N, Myerson R, Doggett S et al (1996) Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol 14:2527–2539

    CAS  PubMed  Google Scholar 

  • Longo WE, Vernava AM III, Wade TP, Coplin MA, Virgo KS, Johnson FE (1994) Recurrent squamous cell carcinoma of the anal canal. Predictors of initial treatment failure and results of salvage therapy. Ann Surg 220(1):40–49

    Article  CAS  PubMed  Google Scholar 

  • Peiffert D, Bey P, Pernot M et al (1997) Conservative treatment by irradiation of epidermoid cancers of the anal canal: prognostic factors of tumoral control and complications. Int J Radiation Oncol Biol Phys 37:313–324

    CAS  Google Scholar 

  • Das P, Bhatia S, Eng C et al (2007) Predictors and patterns of recurrence after definitive chemoradiation for anal cancer. Int J Radiat Oncol Biol Phys 68(3):794–800

    PubMed  Google Scholar 

  • Myerson RJ, Kong F, Birnbaum EH, Fleshman JW, Kodner IJ, Picus J, Ratkin GA, Read TE, Walz BJ (2001) Radiation therapy for epidermoid carcinoma of the anal canal, clinical and treatment factors associated with outcome. Radiother Oncol 61:15–22

    Article  CAS  PubMed  Google Scholar 

  • Constantinou EC, Daly W, Fung CY, Willett CG, Kaufman DS, DeLaney TF (1997) Time-dose considerations in the treatment of anal cancer. Int J Radiat Oncol Biol Phys 39:651–657

    CAS  PubMed  Google Scholar 

  • Papillon J, Montbaron JF (1987) Epidermoid carcinoma of the anal canal. Dis Colon Rectum 30:324–333

    Article  CAS  PubMed  Google Scholar 

  • Schlienger M, Krzisch C, Pene F et al (1989) Epidermoid carcinoma of the anal canal: treatment results and prognostic variables in a series of 242 cases. Int J Radiat Oncol Biol Phys 17:1141–1151

    CAS  PubMed  Google Scholar 

  • Chapet O, Gerard JP, Riche B et al (2005) Prognostic value of tumour regression evaluated after first course of radiotherapy for anal canal cancer. Int J Radiat Oncol Biol Phys 63:1316–1324

    Article  PubMed  Google Scholar 

  • Allal AS, Alonso-Pentzke L, Remadi S (1998) Apparent lack of prognostic value of MIB-1 index in anal carcinomas treated by radiotherapy. Br J Cancer 77((8):1333–1336

    Google Scholar 

  • Noffsinger AE et al (1995) The relationship of human papillomavirus to proliferation and ploidy in carcinoma of the anus. Cancer 75(4):958–967

    Article  CAS  PubMed  Google Scholar 

  • Nilsson PJ, Lenander C, Rubio C et al (2006) Prognostic significance of cyclin A in epidermoid anal cancer. Oncol Rep 16(3):443–449

    CAS  PubMed  Google Scholar 

  • Ajani JA, Winter KA, Gunderson LL et al (2008) Fluorouracil, mitomycin and radiotherapy vs fluorouracil, cisplatin and radiotherapy for carcinoma of the anal canal: a randomised controlled trial. JAMA 199:1914–1921

    Article  Google Scholar 

  • Allal AS, Gervaz P, Brundler MA (2004) Cyclin D1, cyclin E, and p21 have no apparent prognostic value in anal carcinomas treated by radiotherapy with or without chemotherapy. Br J Cancer 91:1239–1244

    Article  CAS  PubMed  Google Scholar 

  • Mawdsley S, Meadows H, James R et al (2004) The role of biological molecular markers in predicting both response to treatment and clinical outcome in squamous cell carcinoma of the anus. ASCO GI (Abstr 183)

    Google Scholar 

  • Ogunbiyi OA, Scholefield JH, Smith JH et al (1993) Immunohistochemical analysis of p53 expression in anal squamous neoplasia. J Clin Pathol 46(6):507–512

    Article  CAS  PubMed  Google Scholar 

  • Jakate SM, Saclarides TJ (1993) Immunohistochemical detection of mutant P53 protein and human papillomavirus-related E6 protein in anal cancers. Dis Colon Rectum 36(11):1026–1029

    Article  CAS  PubMed  Google Scholar 

  • Gangopadhyay S, Abraham J, Lin Y et al (1997) The tumour suppressor gene p53. In: Peters K (ed) Frontiers in molecular biology. Oxford University Press, New York

    Google Scholar 

  • Zwerschke W, Jansen-Durr P (2000) Cell transformation by the E7 oncoprotein of human papillomavirus type 16: interactions with nuclear and cytoplasmic target proteins. Adv Cancer Res 78:1–29

    Article  CAS  PubMed  Google Scholar 

  • Tanum G, Tveit KM, Karlsen KO (1993) Chemoradiotherapy of anal carcinoma tumour response and acute toxicity. Oncology 50:14–17

    Article  CAS  PubMed  Google Scholar 

  • Wong CS et al (1999) Prognostic role of p53 protein expression in epidermoid carcinoma of the anal canal. Int J Radiat Oncol Biol Phys 45(2):309–314

    CAS  PubMed  Google Scholar 

  • Bonin SR, Pajak TF, Russell AH et al (1999) Overexpression of p53 protein and outcome of patients treated with chemoradiation for carcinoma of the anal canal: a report of randomized trial RTOG 87-04. Radiation Therapy Oncology Group. Cancer 85(6):1226–1233

    Article  CAS  PubMed  Google Scholar 

  • Indinnimeo M, Cicchini C, Stazi A et al (1998) The prevalence of p53 immunoreactivity in anal canal carcinoma. Oncol Rep 5(6):1455–1457

    CAS  PubMed  Google Scholar 

  • Allal AS, Waelchli L, Brundler MA et al (2003) Prognostic value of apoptosis-regulating protein expression in anal squamous cell carcinoma. Clin Cancer Res 9(17):6489–6496

    CAS  PubMed  Google Scholar 

  • Indinnimeo M, Cicchini C, Stazi A et al (2001) Prognostic impact of CD31 antigen expression in anal canal carcinoma. Hepatogastroenterology 48(41):1355–1358

    CAS  PubMed  Google Scholar 

  • Litle VR, Leavenworth JD, Darragh TM et al (2000) Angiogenesis, proliferation, and apoptosis in anal high-grade squamous intraepithelial lesions. Dis Colon Rectum 43(3):346–352

    Article  CAS  PubMed  Google Scholar 

  • Petrelli NJ, Shaw N, Bhargava A et al (1988) Squamous cell carcinoma antigen as a marker for squamous cell carcinoma of the anal canal. J Clin Oncol 6(5):782–785

    CAS  PubMed  Google Scholar 

  • Petrelli NJ et al (1992) The utility of squamous cell carcinoma antigen for the follow-up of patients with squamous cell carcinoma of the anal canal. Cancer 70(1):35–39

    Article  CAS  PubMed  Google Scholar 

  • Fontana X, Lagrange JL, Francois E et al (1991) Assessment of “squamous cell carcinoma antigen” (SCC) as a marker of epidermoid carcinoma of the anal canal. Dis Colon Rectum 34(2):126–131

    Article  CAS  PubMed  Google Scholar 

  • Goldman S, Svensson C, Bronnergard M et al (1993) Prognostic significance of serum concentration of squamous cell carcinoma antigen in anal epidermoid carcinoma. Int J Colorectal Dis 8(2):98–102

    Article  CAS  PubMed  Google Scholar 

  • Swampillai A, Williams M, Osborne M et al (2009) A single-center study of the utility of squamous cell carcinoma antigen (SCCAg) levels in epidermoid carcinoma of the anal canal and margin (ECACM) treated with chemoradiation (CRT). J Clin Oncol 27:15s (suppl; Abstr 4117)

    Google Scholar 

  • O’Brien PH, Jenrette JM, Wallace KM et al (1982) Epidermoid carcinoma of the anus. Surg Gynecol Obstet 155:745–751

    PubMed  Google Scholar 

  • Golden GT, Hosley JS (1976) Surgical managemenet of epidermoid carcinoma of the anus. Ann J Surgery 131:275–280

    Article  CAS  Google Scholar 

  • Nigro ND, Vaitkevicius VK, Considine B Jr (1974) Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 17:354–356

    Article  PubMed  Google Scholar 

  • Nigro ND, Seydel HG, Considine B Jr et al (1983) Combined radiotherapy and chemotherapy for squamous cell carcinoma of the anal canal. Cancer 51:1826–1829

    Article  CAS  PubMed  Google Scholar 

  • Cummings BJ, Keane TJ, O’Sullivan B, Wong CS, Catton CN (1991) Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C. Int J Radiat Oncol Biol Phys 21:1115–1125

    CAS  PubMed  Google Scholar 

  • Cummings BJ (1993) Anal cancer – radiation alone or with cytotoxic drugs? Int J Radiat Oncol Biol Phys 27(1):173–175

    CAS  PubMed  Google Scholar 

  • Rich TA, Ajani JA, Morrison WH et al (1993) Chemoradiation therapy for anal cancer: radiation plus continuous infusion of 5-fluorouracil with or without cisplatin. Radiother Oncol 27:209–215

    Article  CAS  PubMed  Google Scholar 

  • Martenson JA, Lipsitz SR, Lefkopoulou M et al (1995) Results of combined modality therapy for patients with anal cancer (E7283) An Eastern Cooperative Oncology Group study. Cancer 76:1731–1736

    Article  CAS  PubMed  Google Scholar 

  • John M, Pajak T, Flam M et al (1996) Dose escalation in chemoradiation for anal cancer: preliminary results of RTOG 92-08. Cancer J Sci Am 2:205–210

    CAS  PubMed  Google Scholar 

  • Friberg B, Svensson C, Goldman S, Glimelius B (1998) The Swedish National Care Programme for Anal Carcinoma – implementation and overall results. Acta Oncol 37:25–33

    Article  CAS  PubMed  Google Scholar 

  • Eschwege F, Lasser P, Chavy A et al (1985) Squamous cell carcinoma of the anal canal treatment by external beam radiation. Radiother Oncol 4:145–150

    Article  Google Scholar 

  • Tanum G, Tveit K, Karlsen KO, Hauer-Jensen M (1991) Chemotherapy and radiation therapy for anal carcinoma. Survival and late morbidity. Cancer 67:2462–2466

    Article  CAS  PubMed  Google Scholar 

  • Konski A, Garcia M, John M et al (2008) Evaluation of planned treatment breaks during radiation therapy for anal cancer: update of RTOG 92-08. Int J Radiat Oncol Biol Phys 72((1):114–118

    Google Scholar 

  • Bosset JF, Roelefsen F, Morgan D et al (2003) Shortened irradiation scheme, continuous infusion of fluorouracil in locally advanced anal carcinomas: results of a phase II study of the of the European Organization for Research and Treatment of Cancer. Eur J Cancer 39:45–51

    Article  CAS  PubMed  Google Scholar 

  • Crehange G, Bosset M, Lorchel F et al (2006) Combining cisplatin and mitomycin with radiotherapy in anal carcinoma. Dis Colon Rectum 50:43–49

    Article  Google Scholar 

  • Newman G, Calverley DC, Acker BD et al (1992) The management of carcinoma of the anal canal by external beam radiotherapy, experience in Vancouver 1971–1988. Radiother Oncol 21:196–202

    Article  Google Scholar 

  • Glimelius B, Pahlman L (1987) Radiation therapy of anal epidermoid carcinoma. Int J Radiat Oncol Biol Phys 13(3):305–312

    CAS  PubMed  Google Scholar 

  • Salmon RJ, Fenton J, Asselain B et al (1984) Treatment of epidermoid anal cancer. Am J Surg 147:43–48

    Article  CAS  PubMed  Google Scholar 

  • Doggett SW, Green JP, Cantril ST (1988) Efficacy of radiation therapy alone for limited squamous cell carcinoma of the anal canal. Int J Radiat Oncol Biol Phys 15:1069–1072

    CAS  PubMed  Google Scholar 

  • Northover J, Meadows H, Ryan C et al (1997) Combined radiotherapy and chemotherapy for anal cancer. Lancet 349:205–206

    Article  Google Scholar 

  • Papillon J (1990) Effectiveness of combined radiochemotherapy in the management of epidermoid cancer of the anal canal. Int J Radiat Oncol Biol Phys 19:1217–1218

    CAS  PubMed  Google Scholar 

  • Tournier-Rangeard L, Mercier M, Peiffert D et al (2008) Radiochemotherapy of locally advanced anal canal carcinoma: prospective assessment of early impact on the quality of life (randomised trial ACCORD 03). Radiother Oncol 87(3):391–397

    Article  CAS  PubMed  Google Scholar 

  • Ferrigno R, Nakamura RA, Dos Santos Novaes PE et al (2005) Radiochemotherapy in the conservative treatment of anal carcinoma: retrospective analysis of results and radiation dose effectiveness. Int J Radiat Oncol Biol Phys 61:1136–1142

    PubMed  Google Scholar 

  • Matthews J; on behalf of TROG 99.02 participants (2005) Early anal canal carcinoma – the Trans-Tasman Radiation Onocology Group (TROG) experience in TROG 99.02 study. Australas Radiol 49(2)A3

    Google Scholar 

  • Ajani JA, Wang X, Izzo JG et al (2009) Molecular biomarkers correlate with disease free survival in patients with anal canal carcinoma treated with chemoradiation. Dig Dis Sci 55(4):1098–1105

    Article  PubMed  CAS  Google Scholar 

  • Hughes LL, Rich TA, Delclos L et al (1989) Radiotherapy for anal cancer: experience from 1979–1987. Int J Radiat Oncol Biol Phys 17(6):1153–1160

    CAS  PubMed  Google Scholar 

  • Allal AS, Mermillod B, Roth AD, Marti MC, Kurtz JM (1997) The impact of treatment factors on local control in T2-T3 anal carcinomas treated by radiotherapy with or without chemotherapy. Cancer 79:2329–2335

    Article  CAS  PubMed  Google Scholar 

  • Conroy T, Ducreux M, Lemanski C et al (2009) Treatment intensification by induction chemotherapy (ICT) and radiation dose escalation in locally advanced squamous cell anal canal carcinoma (LAAC): definitive analysis of the intergroup ACCORD 03 trial. J Clin Oncol 27:15s (suppl; Abstr 4033)

    Google Scholar 

  • James R, Wan S, Glynne-Jones R et al (2009) A randomized trial of chemoradiation using mitomycin or cisplatin, with or without maintenance cisplatin/5-FU in squamous cell carcinoma of the anus (ACT II). J Clin Oncol 27:18s (suppl; Abstr LBA4009)

    Google Scholar 

  • Glynne-Jones R, Meadows H, Wan S et al; National Cancer Research Institute Anal Subgroup and Colorectal Clinical Oncology Group (2008) EXTRA – a multicenter phase II study of chemoradiation using a 5 day per week oral regimen of capecitabine and intravenous mitomycin C in anal cancer. Int J Radiat Oncol Biol Phys 72(1):119–126

    Google Scholar 

  • Eng C, Chang GJ, Das P et al (2009) Phase II study of capecitabine and oxaliplatin with concurrent radiation therapy (XELOX-XRT) for squamous cell carcinoma of the anal canal. J Clin Oncol 27:15s (suppl; Abstr 4116)

    Google Scholar 

  • Olivatto LO, Meton F, Bezerra M et al (2008) Phase I study of cetuximab (CET) in combination with 5-flurouracil (5-FU), cisplatin (CP) and radiotherapy (RT) in patients with locally advanced squamous cell anal carcinoma (LAAC). J Clin Oncol 26(15S):240s (Abstr 4609)

    Google Scholar 

  • Le LH, Chetty R, Moore MJ (2005) Epidermal growth factor receptor expression in anal canal carcinoma. Am J Clin Pathol 124:20–23

    Article  CAS  PubMed  Google Scholar 

  • Van Damme N et al (2008) EGFR and Kras status in anal canal cancer. ASCO 660s (Abstr 15569)

    Google Scholar 

  • Miyaguchi M, Olofsson J, Hellquist HB (1991) Expression of epidermal growth factor receptor in glottic carcinoma and its relation to recurrence after radiotherapy. Clin Otolaryngol Allied Sci 16(5):466–469

    Article  CAS  PubMed  Google Scholar 

  • Hu K, Minsky BD, Cohen AM et al (1999) 30 Gy may be an adequate dose in patients with anal cancer treated with excisional biopsy followed by combined-modality therapy. J Surg Oncol 70:71–77

    Article  CAS  PubMed  Google Scholar 

  • Hatfield P, Cooper R, Sebag-Montifiore D (2008) Involved field low dose chemoradiotherapy for early stage anal carcinoma. Int J Radiat Oncol Biol Phys 70(2):419–424

    CAS  PubMed  Google Scholar 

  • Zelnick RS, Haas PA, Ajlouni M et al (1992) Results of abdominoperineal resections for failures after combination chemotherapy and radiation therapy for anal canal cancers. Dis Colon Rectum 35:574–577

    Article  CAS  PubMed  Google Scholar 

  • Pocard M, Tiret E, Nugent K et al (1998) Results of salvage abdominoperineal resection for anal cancer after radiotherapy. Dis Colon Rectum 41:1488–1493

    Article  CAS  PubMed  Google Scholar 

  • Smith AJ, Whelan P, Cummings B, Stern HS (2001) Management of persistent or locally recurrent epidermoid cancer of the anal canal. With abdominoperineal resection. Acta Oncol 40:34–36

    Article  CAS  PubMed  Google Scholar 

  • Renehan AG, Saunders MP, Schofield PF, O’Dwyer ST (2005) Patterns of local disease failure and outcome after salvage surgery in patients with anal cancer. Br J Surg 92:605–614

    Article  CAS  PubMed  Google Scholar 

  • Sunesen KG, Buntzen S, Tei T et al (2009) Perineal healing and survival after anal canal cancer salvage surgery: 10-year experience with primary perineal reconstruction using the vertical rectus abdominis myocutaneous (VRAM) flap. Ann Surg Oncol 16:68–77

    Article  CAS  PubMed  Google Scholar 

  • Baxter NN, Habermann EB, Tepper JE et al (2005) Risk of pelvic fractures in older women following pelvic irradiation. JAMA 294:2587–2593

    Article  CAS  PubMed  Google Scholar 

  • Derniaud-Alexandre E, Touboul E, Tiret E et al (2003) Results of definitive irradiation in a series of 305 epidermoid carcinomas of the anal canal. Int J Radiat Oncol Biol Phys 56:1259–1273

    Article  Google Scholar 

  • Borzomati D, Valeri S, Ripetti V et al (2005) Persisting anal ulcer after radiotherapy for anal cancer: recurrence of disease or lat radiation-related complication? Hepatogastroenterology 52:780–784

    PubMed  Google Scholar 

  • Cutuli B, Fenton J, Labib A et al (1988) Anal margin carcinoma: 21 cases treated at the Institut Curie by exclusive conservative radiotherapy. Radiother Oncol 11(1):1–6

    Article  CAS  PubMed  Google Scholar 

  • Cantril ST, Green JP, Schall GL, Schaupp WC (1983) Primary radiation therapy in the treatment of anal carcinoma. Int J Radiat Oncol Biol Phys 9(9):1271–1278

    CAS  PubMed  Google Scholar 

  • Papillon J, Montbarbon JF (1987) Epidermoid cancer of the anal canal. A series of 276 cases. Dis Colon Rectum 30:324–333

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centre for Cancer Treatment, Mount Vernon Hospital, Northwood, Middlesex, UK

    Rob Glynne-Jones & Suzy Mawdsley

  2. Mount Vernon Centre for Cancer Treatment, Northwood, Middlesex, HA6 2RN, UK

    Rob Glynne-Jones

Authors
  1. Rob Glynne-Jones
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Suzy Mawdsley
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rob Glynne-Jones .

Editor information

Editors and Affiliations

  1. Div. Medical Oncology, University of British Columbia, West 10th Avenue 600, Vancouver, V5Z 4E6, British Columbia, Canada

    Charles D. Blanke

  2. FB 19 Zentrum der Radiologie, Klinik f. Strahlentherapie, Universitätsklinikum Frankfurt, Theodor-Stern-Kai 7, Frankfurt, 60590, Germany

    Claus Rödel

  3. Evanston Northwestern Healthcare, Northwestern University, Ridge Ave. 2650, Evanston, 60201, Illinois, USA

    Mark S. Talamonti

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Berlin Heidelberg

About this chapter

Cite this chapter

Glynne-Jones, R., Mawdsley, S. (2011). Anal Cancer. In: Blanke, C., Rödel, C., Talamonti, M. (eds) Gastrointestinal Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-13306-0_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-13306-0_14

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-13305-3

  • Online ISBN: 978-3-642-13306-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation